UBS Group
ISPC icon

UBS Group’s iSpecimen ISPC Stock Holding History

UBS Group’s Portfolio ISPC Stock Details ISPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.9K Buy
32,037
+30,693
+2,284% +$127K ﹤0.01% 7279
2026
Q1 		$8.44K Buy
1,344
+1,183
+735% +$13.3K ﹤0.01% 8506
2025
Q4 		$1.68K Buy
+161
New +$4.08K ﹤0.01% 9498
2025
Q3 		– Sell
-351
Closed -$13.8K – 10598
2025
Q2 		$13.8K Sell
351
-192
-35% -$8.94K ﹤0.01% 8685
2025
Q1 		$23K Buy
543
+269
+98% +$20.4K ﹤0.01% 8130
2024
Q4 		$29.1K Buy
274
+237
+641% +$39.5K ﹤0.01% 7625
2024
Q3 		$6.9K Buy
+37
New +$8.04K ﹤0.01% 7948
2024
Q1 		– Hold
0
– -$7 – 9669
2023
Q4 		– Hold
0
– – – 9137
2023
Q3 		– Hold
0
– – – 8968
2022
Q4 		– Sell
-7
Closed -$9K – 10923
2022
Q3 		$9K Buy
7
+4
+133% +$7.16K ﹤0.01% 8580
2022
Q2 		$5K Buy
3
+2
+200% +$4.89K ﹤0.01% 8887
2022
Q1 		$3K Buy
+1
New +$3.91K ﹤0.01% 9451
2021
Q3 		– Sell
-1
Closed -$3K – 9797
2021
Q2 		$3K Buy
+1
New +$5.76K ﹤0.01% 8812

Other funds holding ISPC

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

UBS Group's ISPC Position: Q2 2026 in Review

UBS Group increased its iSpecimen (ISPC) stake by 2,284% in Q2 2026, buying an estimated $127K and bringing the position to 32,037 shares worth $84.9K. The position accounts for ﹤0.01% of the portfolio, ranked #7279.

UBS Group first reported a position in ISPC in Q2 2021 and has held it in 11 quarters since. 8 funds tracked by Wall St. Rank hold ISPC as of Q2 2026.

  • UBS Group held 32,037 shares of iSpecimen worth $84.9K as of Q2 2026.
  • UBS Group bought 30,693 iSpecimen shares in Q2 2026, an estimated $127K.
  • iSpecimen made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7279 holding.
  • UBS Group first reported a position in iSpecimen in Q2 2021 and has held it in 11 quarters since.
  • 8 funds tracked by Wall St. Rank held iSpecimen as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.